Wilson Sonsini Goodrich & Rosati advised Vida Ventures on IP matters related to the transaction. Third Arc Bio Inc., a biotech company, announced a $165 million...
Third Arc Bio’s $165 Million Series A Financing Round
Radionetics’ Strategic Agreement with Eli Lilly
Cooley advised Radionetics Oncology on the transaction, and Wilson Sonsini Goodrich & Rosati acted as patent counsel for Radionetics Oncology and advised the company on patent....
Avidity Biosciences’ $461 Million Common Stock Offering
Latham & Watkins advised Avidity Biosciences, Inc. on the offering, and Wilson Sonsini Goodrich & Rosati advised Avidity on patent matters related to the transaction. Cooley...
Lycia Therapeutics’ $106 Million Series C Financing Round
Wilson Sonsini Goodrich & Rosati advised Venrock on IP related matters related to the transaction. Lycia Therapeutics, Inc., a biotechnology company, announced it raised $106.6 million...
Reneo Pharmaceuticals’ Merger with Onkure
Jones Day and Cooley are representing Reneo Pharmaceuticals, Inc. in the transaction, and Wilson Sonsini Goodrich & Rosati, P.C. is representing OnKure, Inc. Covington & Burling...
Zenas BioPharma’s Upsized $200 Million Series C Financing Round
Wilson Sonsini Goodrich & Rosati advised SR One, Norwest Venture Partners, and Delos Capital on the transaction. Zenas BioPharma, a clinical-stage global biopharmaceutical company, announced an...
Enlaza Therapeutics’ $100 Million Series A Financing Round
Wilson Sonsini Goodrich & Rosati advised Enlaza on IP matters related to the transaction. Enlaza Therapeutics (Enlaza), the first covalent biologic platform company, announced it closed...
Reunion Neuroscience’s $103 Million Series A Financing Round
Wilson Sonsini Goodrich & Rosati advised Novo Holdings on the transaction. Reunion Neuroscience Inc., a clinical-stage biopharmaceutical company, announced the close of a $103 million Series A...
Boundless Bio’s $100 Million IPO
Latham & Watkins and Wilson Sonsini Goodrich & Rosati advised Boundless Bio on the offering, and Cooley advised the underwriters. Boundless Bio, Inc. (Nasdaq: BOLD) a clinical...
vTv Therapeutics’ $51 Million Private Placement Financing
Wilson Sonsini Goodrich & Rosati advised vTv Therapeutics on patent matters related to the transaction. vTv Therapeutics, a clinical-stage biopharmaceutical company, announced the closing of a private...
Janux Therapeutics’ $296.5 Million Common Stock Offering
Cooley advised Janux Therapeutics on the offering and Wilson Sonsini Goodrich & Rosati advised Janux on patent matters. Latham & Watkins advised the underwriters. Janux Therapeutics,...
Avidity Biosciences’ $400 Million Shares Private Placement
Wilson Sonsini Goodrich & Rosati advised Avidity on patent matters related to the transaction. Avidity Biosciences, Inc. (Nasdaq: RNA) announced that it has agreed to sell 15,224,773...